The X-ray structure of the ternary complex of a calcineurin A fragment, calcineurin B, FKBP12, and the immunosuppreseant drug FK506 (also known as tacrolimus) has been determined at 2.5 .~ resolution, providing a description of how FK506 functions at the atomic level. In the structure, the FKBP12-FK506 binary complex does not contact the phosphatase active site on calcineurin A that is more than 10 A removed. Instead, FKBP12-FK506 is so positioned that it can inhibit the dephosphorylation of its macromolecular substrates by physically hindering their approach to the active site. The ternary complex described here represents the three-dimensional structure of a Ser/Thr protein phosphatase and provides a structural basis for understanding calcineurin inhibition by FKBP12-FK506.
Introduction
Following presentation of antigen to the T cell receptor, a cascade of signal transduction events is initiated that ultimately leads to lymphokine gene expression and T cell proliferation (Crabtree, 1989) . Early events associated with this process include an increase in the levels of intracellular Ca 2÷ and the activation of protein kinase C, which together stimulate transcription of early genes in the T cell activation process, such as interleukin-2 (IL-2), IL-3, IL-4, granulocyte/macrophage colony-stimulating factor, and interferon-y (reviewed by Crabtree and Clipstone, 1994) . The therapeutic relevance of this pathway was ascertained as a consequence of the discovery of cyclosporin A (CsA; Borel et al., 1976) and later of FK506 (also known as tacrolimus; Kino et al., 1987) , macrocyclic natural products (Figure 1 ) that exert their inhibitory effects by blocking steps in the T cell activation pathway that are downstream of intracellular Ca 2+ release and protein kinase C activation (Tocci et al., 1989; Emmel et al., 1989) . These two compounds have been approved as drugs for the prevention of graft rejection following organ transplantation and in the treatment of certain autoimmune disorders (reviewed by Borel, 1989; DiPadova, 1994) .
Calcineurin (also referred to as protein phosphatase 2B [PP2B]) is a Ser/Thr PPase whose activity is strongly stimulated by the presence of Ca 2÷ and calmodulin (CAM) (Klee et al., 1988) as part of its essential role in the T cell activation pathway (O'Keefe et al., 1992; Clipstone and Crabtree, 1992) . Although the in vivo target of caicineurin in T cells
has not yet been verified, in vitro studies strongly suggest that one target is the nuclear factor of activated transcription (NF-ATp) . NF-ATp is a lymphocyte-specific transcription factor that translocates from the cytoplasm to the nucleus following intracellular Ca 2÷ release (Flanagan et al., 1991) . Translocation of NF-ATp to the nucleus correlates with its dephosphorylation, presumably by Ca2÷/CaM-stimulated calcineurin. Once in the nucleus, NF-ATp binds to the promoter of the 11_-2 gene and, in concert with other transcription factors, stimulates expression of this early gene in the T cell activation pathway (Northrup et al., 1993; McCaffrey et al., 1993; Jain et al., 1993) .
A wealth of biochemical data now exists that defines calcineurin as the immunosuppressive target of FK506 and CsA (Liu et al., 1991; O'Keefe et al., 1992; Clipstone and Crabtree, 1992) . Both of these compounds inhibit calcineurin in association with their major cellular-binding proteins, FKBP12 and cyclophilin (CyP), respectively. FKBP12 and CyP are small, ubiquitous cytosolic proteins that function enzymatically as cis-trans peptidyl prolyl isomerases. Both enzymes are strongly inhibited upon binding of their cognate ligands, but this inhibition is not sufficient to block T cell signaling (Heitman et al., 1991; Koltin et al., 1991) . Instead, these immunophilin-immunosuppresant complexes (FKBP12-FK506 and CyP-CsA) suppress T cell activation by binding to calcineurin and inhibiting its phosphatase activity (Liu et al., 1991; O'Keefe et al., 1992; Clipstone and Crabtree, 1992) . Calcineurin inhibition by FKBP12-FKS06 or by CyP-CsA correlates with their abiiityto inhibit IL-2 production in T cells (Fruman et al., 1992) , a critical step in T cell proliferation.
Calcineurin is also of considerable interest because it is a member of the Ser/l-hr PPase family of enzymes, for which limited structural information exists. Calcineurin shares high sequence homology with two other members of the Ser/Thr PPase family, PP1 and PP2A (Ito et al., 1989) . In addition, calcineurin displays Ca2÷/CaM dependence, which makes it unique among this family of phosphatases (Klee et al., 1988; Kincaid et al., 1988) . Calcineurin consists of two tightly associated subunits: a 60 kDa catalytic subunit (calcineurin A [CnA] ) and a 19 kDa regulatory subunit (calcineurin B [CnB] ). The CnA subunit shares high sequence homology with PP1 and PP2A, while CnB contains four putative EF hand Ca2+-binding sites (Kretsinger and Nockolds, 1973) , similar to those found in CaM (Babu et al., 1988) . Compared with PP1 and PP2A, however, CnA contains an extra 170 residues at its C-terminus (Ito et al., 1989) . This sequence has been shown to contain the CnB-binding domain (Guerini and Klee, 1989; Sikkink et al., 1995) , a CaM-binding domain (Hashimoto et al., 1990) , and an autoinhibitory domain (AID) (Flanagan et al., 1991) , all of which are involved in regulating calcineurin phosphatase activity.
To understand better the mechanism of calcineurin phosphatase activity, the inhibition of calcineurin by FKBP12-FKS06, and the regulation of this enzyme by as- The corresponding differences in chemical structures of the effector domains of FK506 (A) and rapamycin (B) were at one point believed to be largely responsible for differentiating the calcineurin inhibitory agonist activity of FK506 from the antagonist activity of rapamycin. The effector domains roughly include backbone atoms and substit uents at C18-C23 in the macrecycle and at C26-C34 in the cyclohexyl ring for FK506 and, equivalently, C15-C27 and C34-C42 for rapamycin. R~ = -CH2CHCH2; R2, R3 = -H.
sociation with other proteins, we have solved the crystal structure at 2.5 ,&. resolution of a ternary complex containing the phosphatase and CnB-binding regions of CnA, CnB, and FKBP12-FK506. The structure reported here. provides a detailed view of an immunophilin-immunosuppressant complex inhibiting its cellular target and characterizes the FKBP12-FK506 composite surface that is necessary for calcineurin binding. In so doing, it addresses and resolves much of the speculation that has surrounded this critical event in immunosuppression. This study also provides the three-dimensional structure of an important class of enzymes in signal transduction pathways, the Ser/ Thr PPases.
Results

Architecture of the Ternary Complex
The components of the ternary complex associate to form a roughly rectangular structure with overall dimensions of 87 ,~ x 61 ~, x 37 ,~, (Figure 2 ). The largest component is a proteolytic fragment of CnA (residues 17-392) that incorporates the phosphatase catalytic domain and the CnB-binding region; missing from the CnA fragment in the structure are the CaM-binding and autoinhibitory regions. The globular CnA phosphatase domain is characterized by a 13-sandwich motif that forms the core of the enzyme. This motif is seen in other proteins such as DNase I (Oefner and Suck, 1986 ) and exonuclease III (Mol et al., 1995) , but the degree of structural similarity to CnA is limited. Perhaps the most striking feature of the ternary complex, however, is the 22 residue CnB-binding ~ helix (BBH) that extends nearly 40,~ away from the surface of the phosphatase domain and is connected to it by a short linker sequence. The CnB component of the ternary complex includes two CaM-like domains that form a hydrophobic groove that grasps the upper surface of the BBH. The underside of the BBH remains completely exposed ( Figure  2 ), and it is to this exposed region of the BBH that the FKBP12-FK506 complex binds. Interestingly, the calcineurin active site, which is located on the surface of the phosphatase domain, is not in contact with any other cornponent of the ternary complex; its nearest neighbor, FKBP12, is more than 10 ,~ removed.
Architecture of CnA: The Phosphatase Domain
The phosphatase domain of CnA forms an ellipsoid approximately 35 ~, × 35 ,~, x 45 ,~, in size. The core of the domain consists of two mixed 13 sheets, termed sheet 1 and sheet 2, that are flanked on one side by a mixed a/[~ structure and on the other side by an all ~ structure ( Figure  3 ). The two central 9 sheets form a distorted 13 sandwich that contains an open and closed end. At the closed end of the 13 sandwich, sheet 2 extends above sheet 1, resembling the Greek letter X, with a separation angle between the sheets of approximately 30 ° . The inner core of the sandwich is populated with hydrophobic residues: smaller side chains at the closed end of the core and larger ones at the open end. Strands 96, ~10, and 1312 from sheet 1 are parallel and run in the direction of the closed end of the sandwich, as do strands 134, 93, 92, and 1514 in sheet 2. Following 1514, the sequence forms an extended region of approximately 24 residues that connects to the BBH. Residues 340-348, while still part of the phosphatase core, also participate in multiple contacts with CnB and can be considered part of the CnB-binding region. Additional contacts between CnA and CnB occur at the N-terminus of CnA and in loop L1, where a salt bridge is formed between Glu-53 of CnA and Lys-134 of CnB. These interactions appear to help stabilize the extended CnB-BBH structure.
The phosphatase active site is located above the closed end of the 13 sandwich, formed by the convergence of several loops and by that portion of sheet 2 that extends above the 15 sandwich (Figures 2 and 3) . Active site residues are found in loops L2, L3, L4, and L6 and at the C-termini of strands 152 and 93. The somewhat shallow active site pocket is located in the middle of a larger, curved channel that runs along the top of sheet 1 and helix ~9 ( Figures  3 and 4) . This channel should accommodate access by larger phosphorylated substrates to the active site and may help provide specificity through interactions with residues surrounding the phosphorylated side chain of the -1314) . The surface of sheet 1 is covered by three (~ helixes and a threestranded 13 sheet while sheet 2 is covered by an all a-helical structure. The active site is located at the closed end of the 13 sandwich, corresponding to the two metal ions shown as spheres, and the bound phosphate in ball-and-stick format. This figure was generated using the program RIBBONS (Carson, 1991) . substrate. The broad, shallow active site is also consistent with observations that other SerFFhr PPases are able to catalyze the dephosphorylation of certain phosphotyrosine substrates as well as their natural substrates (DonellaDeana et al., 1994) . The active site ( Figure 4 ) contains two metal ion sites that are modeled as Zn 2+ and Fe 3÷, in addition to a single phosphate ion, whose presence in the structure may be the result of including 100 mM potassium phosphate buffer in the crystallization conditions. The assignment of these two metals in the active site is consistent with atomic absorption experiments that found stoichiometric amounts of Zn 2÷ and Fe 3÷ in CnA (King and Huang, 1984) . It is also in agreement with the crystal structure of purple acid phosphatase (PAP), which also includes a Zn2+/Fe 3÷ pair in its active site (Strater et al., 1995) and appears to be similar to calcineurin in this region. The Zn 2÷ and Fe 3÷ atoms are identified as such on the basis of their interactions with surrounding ligands and are separated by 3.0 ,&. in the active site. The Zn 2÷ is coordinated by the side chains Asp-118 (O52), Asn-150 (O51), His-199 (N~2), a.nd His-281 (N81) and by a phosphate oxygen. This coordination sphere is identical to that of the Zn 2+ in PAP except for the phosphate, which is not present in that structure (Strater et al., 1995) . The Fe 3÷ is coordinated by Asp-90 (O51), His-92 (N~2), Asp-118 (O~52), a phosphate oxygen, and a water molecule. In the PAP structure, a Tyr and a His substitute for His-92 and the water in CnA, respectively, with the other ligands remaining the same. In both structures an Asp side chain acts as a monodentate bridging ligand between the metals (Asp-118 in CnA versus Asp-164 in PAP).
In the current model, the preferred octahedral coordination for Fe 3+ would be fully satisfied by a single bridging ligand, possibly a water or OH-, opposite the bridging oxygen of Asp-118 ( Figure 4B ). At this stage of refinement, however, and in the vicinity of two metal ions, it is difficult to assign electron density to this bridging water molecule with any confidence. A similar bridging OH-ligand was modeled into the Zn2+/Fe 3÷ metal cluster of PAP (Strater et al., 1995) , along with two nonbridging ligands that would be represented by the phosphate oxygens in our structure. In the calcineurin ternary complex, a bridging water molecule can be modeled to be within 2.9 ,&, of the phosphorous atom and colinear with one of the P-O bonds, a geometry that is favorable for nucleophilic attack on the phosphorous. This water would also be stabilized by its interaction with the carbonyl oxygen of His-281.
In addition to coordinating both metals, the bound phosphate in the active site is stabilized by interactions with the guanidinium groups of Arg-122 and Arg-254 and with the N~2 of His-151. Arg-254 is stabilized through a bidentate interaction with the carboxylate of Asp-234, as it extends into the active site from loop L5, which is 8.5 ~. away from the phosphate. In turn, His-151 is situated in the active site, within hydrogen bonding distance of the most solvent-exposed oxygen of the bound phosphate. This could represent the leaving oxygen of the substrate based on its location opposite the putative water/OH-ligand. Within this constellation, His-151 serves as a proton donor to the leaving group on the Ser side chain in an SN2-type mechanism. The His-151 side chain is stabilized by a hydrogen bond to Asp-121, with the main chain conformation stabilized by the next residue, Glu-152, which makes a pair of hydrogen bonds to main chain nitrogens surrounding the metal-bridging ligand, Asp-118.
BBH
The BBH is a five-turn amphipathic c~ helix (residues 350-370) to which both CnB and the binary FKBP12-FK506 ,complex bind ( Figure 5 ). The top half of the BBH is completely nonpolar and forms a complementary surface for the hydrophobic groove formed by CnB (see below). The solvent accessible surface area lost by the BBH upon CnB binding is 1410 ,&2, which leaves 920 ,~2 solvent accessible surface area remaining. The tip of the BBH abuts the N-terminal helix of CnB, which lies perpendicular to the axis of BBH and caps the end of the BBH-binding groove. The lower half of the BBH is polar except for a small hydrophobic patch near its N-terminus. This patch forms the contact surface with the FKBP12-FK506 complex.
Architecture of CnB
The structure of CnB consists of two globular Ca2+-binding domains flanked by a long C-terminal ~ strand. Each Ca 2÷-binding domain contains two Ca2+-binding EF hand motifs. Domain 1 (residues 1-84) connects to domain 2 (residues 86-155) via an ~ helix that is kinked at Gly-85. Domains 1 and 2 are arranged linearly along the BBH and, together with the amphipathic C-terminal strand, form a 33 A long hydrophobic groove into which the top half of the BBH is embedded ( Figure 5 ). The two CnB domains can be approximately superimposed by a translation of 22 ~. along the BBH. This arrangement of Ca2+-binding domains on an a helix is in contrast with the way CaM binds to ~ helices. For example, the nuclear magnetic resonance (NMR) structure of CaM bound to light chain myosin (Ikura et al., 1992) shows the two CaM domains arranged on opposite sides of an ~ helix and related by a 2-fold rotation ( Figure  6 ). A similar domain relationship can be seen in the X-ray structure of CaM complexed with the CaM-binding domain of the CaM-dependent protein kinase II (Meador et al., 1992) .
The three-dimensional structure of each of the pairs of EF hands (EF1 and EF2 in domain 1 and EF3 and EF4 in domain 2) in CnB is highly conserved with those of other members of the superfamily; the intradomain Ca2+-Ca 2÷ distances in CnB are nearly identical to those found in CaM, for example. In all four EF hands, Ca 2+ is coordinated by five ligands. These are Asp-30, Asp-32, Ser-34, Glu-41, and the Ser-36 carbonyl for EF1 ; Asp-62, Asp-64, Asn-66, Glu-73, and the Gly-68 carbonyl for EF2; Asp-99, Asp-101, Asp-103, Glu-110, and Tyr-105 carbonyl for EF3; and Asp-140, Asp-142, Asp-144, Glu-151, and Arg-146 carbonyl for EF4. This suggests that all four sites are high affinity Ca 2+ sites and is consistent with the electron density maps, which show all four to be equally occupied, and with NMR observations made by Kakalis et al. (1995) .
The N-terminal glycine of CnB is covalently linked to myristate, a 14-carbon saturated fatty acid. The myristate group is located at the extreme end of the calcineurin com- plex, near the end of the BBH (see Figure 2) . It is connected to the N-terminal helix of CnB by a 15 residue loop and lays against and runs parallel to that helix, which is itself hydrophobic (Figure 7 ). Myristylation, a posttranslational modification, is often discussed in the context of anchoring proteins to membranes (Resh, 1994) , though it can also serve as a stabilizing structural element in a protein (Ames et al., 1995) .
Structure of FKBP12-FK506
The conformation of FKBP12 in the ternary complex is nearly identical to that found in the structure of the FKBP12-FK506 binary complex (van Duyne et al., 1991a; Becker et al., 1993; Wilson et al., 1995) . Superposition of FKBP12 from the ternary and binary complexes gives a root-meansquare (rms) deviation of 0.59 ,~ for Ca atoms. Similarly, the conformations of FK506 are almost identical in the two complexes, with an rms difference of 0.21 ,~ for all nonhydrogen atoms, excluding those from the highly flexible C21 allyl group. However, the relative position of FK506 to FKBP12 differs in the ternary and binary complexes, as can be seen in Figure 7 , which shows a superimposition of FKBP12 molecules from the two complexes. In the ternary complex, FK506 is rotated by about 8 ° from the body of FKBP12, resulting in a displacement of 1.7 ~, for the C21 carbon at the base of the allyl group. A concomitant displacement of the His-87 to lie-90 loop in FKBP12 is observed as well. This rotation allows the allyl and, to a lesser extent, cyclohexyl moieties of FK506 (see Figure  1 ) to contact the BBH more intimately. One consequence of this rotation is the loss of a hydrogen bond between t h e Glu-54 carbonyl oxygen of FKBP12 and the C24 hydroxyl group of FK506 in the ternary complex.
FKBP12-FK506 Binding to Calcineurin
The FKBP12-FK506 complex binds to calcineurin at the base of the BBH, making contacts with the BBH, CnB, and the phosphatase domain of CnA (Figures 2, 7 , and 8). The solvent accessible surface area lost to each component upon FKBP12-FK506 binding is 320 ,~,2, 479 ~,2, and 512 ~2. FKBP12-calcineurin contacts surround the FK506 ligand and cluster to three distinct regions of the FKBP12 sequence: His-87 to lie-90, Asp-37 to Asp-41, and Arg-42 to Phe-46. These regions contact the BBH, the phosphatase domain, and CnB, respectively (Figures 7  and 8 ). Several of these residues, including Asp-37, Arg-42, His-87, and lie-90, had previously been identified as mediators of calcineurin binding by FKBP12-FK506 through site-directed mutagenesis experiments (Aldape et al., 1992; Yang et al., 1993; Futer et al., 1995) . The principal site of interaction between FK506 and calcineurin is a predominantly hydrophobic cleft located at the interface of CnB and the BBH. Side chains that form the cleft come from residues Leu-343, Pro-344, Trp-352, Ser-353 (CI3), and Phe-356 on the BBH and residues Leu-115, Met-118, Va1-119, and Leu-123 from CnB. This binding cleft is approximately 8 ,~ long and has surface properties complementary to the C15-C21 region of FK506. The majority of contacts made by FK506 are from C15-C17 and the C21 allyl group. The allyl group extends into a deep pocket within the hydrophobic cleft, making a number of favorable van der Waals contacts with main chain and side chain atoms. The FK506-calcineurin interaction is further stabilized by an unusual bifurcated hydrogen bond between the N~I of Trp-352 and the C13 and C15 methoxy oxygens of FK506.
Discussion
Protein phosphorylation and dephosphorylation regulate a multitude of cellular processes, and an understanding of these events has been the focus of intensive research (Cohen, 1989; Hunter, 1995, and references therein) . The Ser/Thr PPase family of enzymes are important participants in these regulatory processes (reviewed by Cohen and Cohen, 1989; Shenolikar, 1994) . The recent discovery that calcineurin is a major cellular target of immunosuppressive drugs such as FK506 and CsA (Liu et al., 1991; O'Keefe et al., 1992; Clipstone and Crabtree, 1992) has prompted attempts at further characterization of this key component of the T cell activation pathway. The ternary complex described here presents not only the three-dimensional structure of a Ser/Thr PPase, but also a detailed view of an immunophilin-immunosuppressant complex inhibiting its cellular target.
CnA as a Ser/Thr Phosphatase
Mammalian CnA sequences are strongly homologous, typically displaying greater than 90% identity (Kincaid et al., 1990; Ito et al., 1989) . CnA also shares over 40% sequence identity (60% sequence conservation) with two other members of the Ser/Thr PPase family, PP1 and PP2A (Ito et al., 1989) . Mapping the sequences of these Ser/Thr PPases onto the CnA structure (E. E. K., unpublished data) suggests that members of all three subfamilies should share similar folds, as well as similar active sites. This is based on the fact that many of the residues within the core of the I~ sandwich and in the helices facing the central 13 sandwich (~3 and ~4) are conserved. More importantly, nearly all of the residues that define the active site of CnA in this structure, both in terms of metal ion coordination and phosphate binding, are identical in all known Ser/Thr PPase sequences (P. R. C., unpublished data). This includes the sequence G NHE/D (residues 149-152 in CnA), which is present in all homologous Ser/Thr PPase sequences as well as in a number of phosphoesterase sequences (Zhuo et al., 1994) . This sequence in CnA includes two residues (Asn-150 and His-151) that form part of the active site and one residue (Glu-152) that makes a pair of backbone hydrogen bonds around Asp-118, the bridging ligand to the active site metals.
The likelihood of structural similarity between these subfamilies of the Ser/Thr PPases is further supported by a comparison of the CnA active site residues with the results of mutagenesis studies carried out on the Ser/Thr PPase from bacteriophage X (X-PPase). This study found that conservative mutations in X-PPase of residues corresponding to Asp-90, His-92, and Asp-118 in CnA, all involved in metal coordination, resulted in a 106-fold decrease in Koa~ (Zhuo et al., 1994) . Additionally, mutation of His-76 in X-PPase (His-151 in CnA) led to a 10%fold decrease in K~at, indicating that this residue is critical for enzymatic activity.
Based on the high sequence conservation of all Ser/Thr PPases of the PP1, PP2A, and PP2B subfamilies in the vicinity of the active site, the elucidation of residues that are important for catalysis based on the X-PPase studies, and the pattern of metal ion coordination in the active site in our structure, one can speculate on a plausible mechanism for the phosphatase activity of CnA and related Ser/ Thr PPases. A water or OH-group, acting as a bridging ligand between Zn 2÷ and Fe 3÷, would be within 2.9 ,~. of the phosphorous and directly in line with the P-O scissile bond of the substrate (Figure 4) . This ligand could act as a nucleophile and attack the phosphorous via an SN2 mechanism, leading to a pentacoordinate transition state structure, which would be stabilized by phosphate oxygen contacts to Asn-150 (N51), Arg-122 (NH2), and Arg-254 (NH2). His-151, stabilized by a salt bridge to Asp-121 and 2.8 ,~. from the probable leaving oxygen, would then be in position to donate a proton to the leaving Ser side chain. Such a mechanism is consistent with the preferred orientation of attacking and leaving groups for an SN2-type reaction and with the results of mechanistic studies on CaM and PAP that suggest that dephosporylation of substrate occurs with net inversion of configuration and without formation of a phosphoenzyme intermediate (Martin and Graves, 1994; Mueller et al., 1993) .
Interaction of FKBP12-FK506 with Calcineurin
The ternary complex structure provides atomic level details of the specific interactions that make FK506 an effective calcineurin inhibitor and immunosuppressant. It also demonstrates that the composite surface of the FKBP12-FK506 complex is critical for calcineurin recognition and binding. This is seen clearly in Figure 8 , which shows the FKBP12-FKS06 contact surface color coded as a function of distance to calcineurin atoms. There are no major conformational changes in the FKBP12-FK506 binary complex upon binding to calcineurin, as might be expected from a comparison of the FKBP12 native (Wilson et al., 1995) , FKBP12-FKS06 (van Duyne et al., 1991a (van Duyne et al., , 1993 Becker et al., 1993; Wilson et al., 1995) , and FKBP12-rapamycin (van Duyne et al., 1991b (van Duyne et al., , 1993 Wilson et al., 1995) complexes. There are, however, subtle but significant changes scattered throughout FKBP12 at the calcineurin interface. These changes occur in backbone as well as side chain atoms. The backbone His-87 to lie-90 loop of FKBP 12, for example, shifts by about 1 .~. on contact with CnA; in turn, the critical lie-90 residue (Yang et al., 1993; Futer et al., 1995) adopts a different side chain conformation. The flexibility of this particular loop has been noted in the native and binary complex structures (Wilson et al., 1995) and in the structures of FK506 complexes with effector surface mutants of FKBP12 (Itoh et al., 1995; S. Itoh and M. A. N., unpublished data) and FKBP13 (J. P. G. et al., unpublished data). It is possible that some of this flexibility is necessary to optimize complementarity between the calcineurin and binary complex effector surfaces (see Figure 8 ). An in-depth analysis of FKBP mutagenesis studies in the context of the calcineurin structure will be discussed elsewhere.
Based on the properties of FK506 analogs, it has been proposed that the ligand contacts caicineurin through three distinct regions: the C29-C34 cyclohexyl moiety, the C21 allyl region, and the C15-C18 region (Figure 1) . As in the case with site-directed mutants of FKBP12, chemical modification (Goulet et al., 1994) of FK506 in these regions can dramatically decrease calcineurin inhibitory activity. Conversely, other regions of the ligand can tolerate more radical changes without compromising potency. For example, significant modifications to the cyclohexyl ring and its substituents have little or no effect on binding to FKBP12, and several analogs of this class are still potent inhibitors of calcineurin (Goulet et al., 1994) . This is clearly explained by the ternary complex structure, which shows that the the cyclohexyl moiety is partially exposed to solvent and seems to lack tight, specific contacts with calcineurin. On the other hand, even slight modifications of the C21 allyl group of FK506 can significantly reduce the calcineurin inhibitory potential of the FKBP12 complexes with the resultant analogs. In the case of the immunosuppressive FK506 analog ascomycin, for example, truncation of the C21 allyl group to ethyl leads to a 20-fold reduction of calcineurin binding; elongation of this substituent effectively eliminates binding Goulet et al., 1994) . A cursory examination of the crystal structure of the ternary complex shows the C21 allyl of FK506 packed tightly in a hydrophobic binding pocket whose size suggests that a three-carbon substituent at that position would be optimal. The structure also suggests an explanation for the loss of activity associated with the 18-hydroxy ascomycin analog L-685,818 (Becker et al., 1993) , since it indicates that either the R or S substitution would place the 18-hydroxy group in an unfavorable hydrophobic environment. A comprehensive analysis of the possible consequences on the ternary complex of known FK506 analogs will be discussed in detail elsewhere.
Inhibition of Calcineurin by FKBP12-FK506
In the ternary complex structure, FK506 is located 25 ,~ from the phosphatase active site and, as such, does not participate directly in calcineurin phosphatase inhibition. Instead, FK506 mediates calcineurin phosphatase inhibition and the immunosuppression that follows by forming a co~nposite effector surface with structural elements from FKBP12, which then recognize and bind tightly to calcineurin. It is the bound FKBP12 that physically blocks access by NF-ATp (and possibly other macromolecular substrates) to the calcineurin phosphatase active site, not by a direct interaction with that site, but by virtue of its eclipsing position relative to it. It should be noted that the bound FKBP12 is no closer than 10 ,~. from the phosphatase site (Figure 2 ). This mode of inhibition is consistent with studies on calcineurin inhibition by FKBP12-FK506 that demonstrated that the dephosphorylation of a 20 residue phosphopeptide by calcineurin is strongly inhibited by FKBP12-FK506, whereas dephosphorylation of p-nitrophenyl phosphate is actually increased by a factor of 3 (Liu et al., 1991) .
It is interesting to speculate, based on the structure of the calcineurin-FKBP12-FK506 complex, about the nature of the interaction between calcineurin and the immunosuppressive CyP-CsA complex. At least three sets of experimental results suggest that FKBP12-FK506 and CyP-CsA complexes bind to similar a region of calcineurin. One result shows that the two immunophilin-ligand complexes compete for binding to calcineurin (Liu et al., 1991) , suggesting that their binding sites at least partially overlap. Secondly, mutations in the latch region of CnB, residues 118-124, lead to loss of inhibition by CyP-CsA (Milan et al., 1994) . In the structure presented here, two thirds of the total surface area contact between CnB and the FKBP12-FK506 complex comes from this latch region, suggesting that both immunophilins bind to similar regions of CnB. Finally, CnA mutation of Leu-312, which is in loop L7, also results in CsA resistance. The L7 loop of CnA is in close proximity to the FKBP12-FK506 complex in the ternary structure, again suggesting that CyP-CsA binds in the same general location. Since, from our structure, it appears that the precise positioning of the FKBP12-FK506 complex on calcineurin is not critical for blocking access of substrates to the active site and providing inhibition, the binding of CyPCsA to a similar region of calcineurin would appear to inhibit the phosphatase activity of this enzyme by the same mechanism.
high concentration (Aldape et al., 1992) , and rapamycin acts as an antagonist of the immunosuppressive action of FK506. This lack of calcineurin inhibitory activity can be explained by a superimposition of the FKBP12-rapamycin binary complex structure (Wilson et al., 1995) on the structure of FKBP12-FK506 seen in the calcineurin ternary complex. As seen in Figure 7 , if FKBP12-rapamycin were to bind the calcineurin complex, the larger "effector domain" region of rapamycin relative to FK506 (Figure 1) would then interpenetrate the backbone of CnB at residues 118-119 as well as the side chains of Phe-356 and Lys-3~60 in the BBH of CnA. In addition to those steric violations, rapamycin lacks an equivalent to the C21 allyl in FK506 and would not be able to participate in key hydrophobic interactions with CnA and CnB.
The FKBP12-Rapamycin Complex Does Not Inhibit Calcineurin
The peptidyl prolyl isomerase activity of FKBP12 is also potently inhibited by rapamycin (Vezina et al., 1987) , a natural product isolate that is an immunosuppressant by a mechanism that does not involve calcineurin inhibition Bierer et al., 1990) . In fact, the FKBP12-rapamycin complex does not inhibit calcineurin, even at
CaM Binding and AIDs
In addition to the phosphatase and CnB-binding domains, CnA also possess a CaM-binding domain (Kincaid et al., 1988 ) and a C-terminal AID (Hashimoto et al., 1990) ; the latter two elements are not present in the structure described here. Considerable biochemical, mutagenic, and kinetic data have been accumulated with respect to the activity of these domains, however, and these data can The molecular surface of the FKBP12-FK506 complex is color coded according to its distance from CnA and CnB, ranging from blue (d > 10 ,a,) to white (d = 6 ,~,) to red (<3.5 ,~). In the ternary complex, there are extensive interactions between calcineurin and both FKBP12 and FK506. The figure was produced using GRASP (Nicholls et al., 1991) . The view on the right is rotated by 90 ° .
now be reexamined in light of the structure of the cal-. cineurin ternary complex presented here, to'provide a clearer understanding of the Ca2+/CaM-modulated regulation of calcineurin. A minimal inhibitory peptide within the AID has been delineated to a stretch of about 25 residues (457-482) near the the C-terminus of CnA (Perrino et al., 1995) . When this region is removed, CnA becomes a Ca2+-independent phosphatase whose interaction with FKBP12-FK506 also becomes Ca2+/CaM independent (O' Keefe et al., 1992) . Moreover, preliminary results suggest that an isolated AID synthetic peptide added to the calcineurin-FKBP12-FK506 complex can inhibit the activity of the phosphatase toward small substrates (J. A. T., unpublished data). Taken together, this evidence suggests that the AID binds at or very near the active site of CnA and that its covalent attachment to the rest of CnA is a necessary element for Ca2+/ CaM modulation of the enzyme. Based on this information and on the structure presented here, a plausible model for the autoregulation of calcineurin can be proposed. In this model, the CaM-binding domain, which is predicted to be an amphipathic a helix (Kincaid et al., 1988) , would lie underneath the BBH, held at one end by a link to the C-terminus of the BBH and on the other by a link to the AID. Such an arrangement would place the AID in the immediate vicinity of the active site, where it would be able to exert its autoinhibitory function. In this model, the CaM-binding helix and perhaps the AID would block access by FKBP12-FK506 to its binding site on CnB-BBH in the absence of Ca2+/CaM. When Ca 2÷ and CaM are added to the system, the activated CaM could then bind to the CaM-binding helix in a manner similar to that depicted in Figure 6 and would disrupt its interaction with the BBH. This would simultaneously remove the AID from the active site, and in this condition, both phosphorylated substrates and FKBP12-FK506 would enjoy access to their binding sites on calcineurin.
Myristylation of CnB
Protein N-myristylation has been previously reviewed (Gordon et al., 1991 ; Resh, 1994) . It is a largely irreversible posttranslational modification that is strictly dependent on the presence of an N-terminal glycine residue to accept the direct coupling of the 14-carbon myristic acid moiety; other sequence motifs may also be present to determine the specifity of this reaction. Protein myristylation can have varied consequences with respect to the function of the modified protein. Perhaps the most dramatic of these is exemplified by the myristoylated Ca2+-binding protein recoverin (a member of the EF hand superfamily of Ca 2+-binding proteins and a close relative of CnB), in which Ca 2+ binding acts as a switch, leading to the extrusion of myristate and binding of the protein to membrane (Flaherty et al., 1993; Ames et al., 1995) . An alternative view would consider the myristate posttranslational substituent as simply another constitutent of the structure of CnB that might lead directly to a stabilization of the protein, as shown in the stabilization of recombinant cAMP-dependent protein kinase as a result of its myristylation (Yonemoto et al., 1993) .
Conclusion
The immediate mechanism of calcineudn phosphatase inhibition by FK506 that leads to imunosuppression has now been delineated by the structure of the ternary complex presented here. It is striking that the FKBP12-FK506 complex exerts its inhibitory effects on calcineurin at a position that is distant from the active site. Our structure strongly reinforces existing biochemical evidence that the FKBP12-FK506 binary complex inhibits calcineurin phosphatase activity without a direct active site interaction. Instead, its physical presence on calcineurin blocks access to the phosphatase active site by macromolecular phosphorylated substrates such as the NF-ATp transcription factor. The structure of CnA described here also provides insights into the structures and mechanisms of a broad family of Ser/Thr PPases, many of which are involved in aspects of cellular regulation. The structural information presented here should be invaluable in the design of specific experiments to explore the therapeutic potential of inhibitors of this and related enzymes. (,&,) 0.020 rms bond angle (degrees) 3.77
All heavy atom soaks along with tranfers to cryoprotectants were done at 4°C. Native 1, PIP, and Pb(NO3)2 (first set) data were-collected from crystals stabilized in 50 mM HEPES (pH 7.5) and 12% PEG 8000. Crystals were transferred to 50 mM HEPES (pH 7.5), 12% PEG 8000, and 22% glycerol before flash freezing for data collection. Native 2, HgCI2, Pb(NO3)2 (second set), and K2PtCI4 data were collected from crystals stabilized in 0.1 M potassium phosphate (pH 7.5) and 12% PEG 8000 and cryoprotected in 0.1 M potassium phosphate (pH 7.5), 9% PEG 8000, and 23% ethylene glycol. All data sets were collected on a Rigaku R-Axis I Ic imaging plate area detector. R~ym = Ell -<I>I/T-,I, where I = observed intensity, <1> = average intensity obtained from multiple observations of symmetry related reflections. Riso = Z:IIFp. -IFPII/~IFPI, where IFpI = protein structure factor amplitude, IFp.I = heavy-atom derivative structure factor amplitude. Phasing power = rms (IFHI/E), where IF.I = heavy-atom structure factor amplitude, and E = residual lack of closure.
Experimental Procedures Sample Preparation and Crystallization
A crude population of mixed isozymes of bovine calcineurin was isolated from calf brains (1 year old or less), as described by Sharma and Wang (1986) . The remaining noncalcineurin contaminants were removed by anion exchange chromatography using DEAE-Sepharose (Pharmacia) equilibrated in 20 mM Tris-HCI, 2 mM I~-mercaptoethanel, 1 mM magnesium acetate, 1 mM imidazele, 0.1 mM EGTA, 0.t mM PMSF (pH 7.6) at 4°C. Proteins were eluted with a linear gradient of 0-300 mM NaCI (10 column volumes) in the same buffer system at 4°C. Calcineurin, which eluted as the main peak, was then fractionated into numerous isoforms by hydrophobic interaction chromatography. Protein was exchanged into a buffer consisting of 50 mM Tris-HCI, 1.4 M ammonium sulfate, 5% (v/v) glycerol, 2 mM 13-mercaptoethanol, 1 mM EGTA (pH 7.5) at 20°C and loaded onto a Hydropore-HIC (Rainin) column (2.0 cm x 30 cm) equilibrated in the same buffer. The calcineurin isozymes were etuted at 20°C with a linear gradient (8 column volumes) from 1.4 M to 0 M ammonium sulfate, keeping the other buffer parameters constant. The first peak, which represented about 60% of the total protein, was concentrated and dialyzed into 25 mM Tris-HCI, 0.1 mM MnCI2, 0.1 mM CaCI2, 2 mM 13-mercaptoethanol (pH 8.0) at 4°C. A binary complex of recombinant bovine FKBP12 and FK506 was prepared, as described previously (Wilson et al., t995) . This was dialyzed into 25 mM Tris-HCI, 0.1 mM MnCI2, 0.1 mM CaCI2, 2 mM ~-mercaptoethanol (pH 8.0) at 4°C and then combined with the pure calcineurin at a 1:1.3 molar ratio (calcineurin:FKBP12-FK506 complex) and a final total protein concentration of 1-2 mg/ml. The calcineurin-FKBP12-FK506 complex was allowed to equilibrate for 1 hr at 4°C before the addition of Clostripain (IUB 4.4.22.8, Worthington) at 3 mg per 100 mg of complex. Proteolytic digestion of the complex was allowed to proceed for 3-4 days at 4°C before being concentrated to 15-20 mg/ml (50-100 mg of total protein) and then size fractionated at 4°C on a column system of Sephacryl S-300 HR (2.6 cm x 100 cm x 3 cm) equilibrated in the same buffer. The main peak, which eluted soon after the void volume, consisted of the intact complex, containing truncated calcineurin (43 kDa A chain, unmodified B chain), FKBP12, and FK506. Clostripain and unbound FKBP12-FK506 eluted later. The complex was concentrated by ultrafiltration to 25-55 mg/ ml and centrifuged at 40,000 x g for 10-15 min.
Crystals were obtained from these solutions, using hanging drops (initially 8 #.1 total, 25% precipitant) suspended over a precipitant reservoir of 8% PEG 8000, 0.1 M potassium phosphate, 20 mM 13-mercaptoethanol. Crystals appeared within 3-4 days at 4°C and reached maximal size in about 2-3 weeks. They belong to space group P21212~ with unit cell dimensions a = 90.3 ,~, b = 97.6 ,~,, and c = 117.8 ,~ and one ternary complex per asymmetric unit. SDS-PAGE analysis of redissolved crystals showed the protein composition was indistinguishable from that found in the mother liquor. Complete details concerning the purification and characterization of the calcineurin, ternary complex formation, in vitro proteolysis, and crystallization and characterization of the truncated complex will be presented elsewhere (J. A. T. et al., unpublished data).
Data Collection and Processing
Structural data are summarized in Table 1 . Initial heavy atom searches were carried out with crystals stabilized in 50 mM HEPES (pH 7.5) and 12% PEG 8000 to remove phosphate during the heavy atom soaks and to help stabilize the ~-axis length, which varied by up to 4 ,~, between native crystals in phosphate buffer. This stabilization and subsequent cryoprotection in solutions containing 50 mM HEPES (pH 7.5), 12% PEG 8000, and 220/0 (w/v) glycerol chang=ed the unit cell dimensions to a = 89.3 ,~, b = 92.1/~, and c = 118.5 A. Two derivatives were obtained under these conditions using platinioiodoplatinate (PIP) and Pb(NO3)2, the latter on crystals that had been pretreated with EGTA to remove Ca 2. from the metal-binding sites on CnB (Table 1 ). All data sets were collected from crystals frozen and maintained at -165°C in a dry nitrogen gas stream (Molecular Structure Incorporated). Data were acquired by oscillation photography on a Rigaku R-AXIS IIC phosphorimaging area detector mounted on a Rigaku RU200 rotating anode generator (Molecular Structure Incorporated), operating at 50 kV and 100 mA. Measured intensitJes were integrated, scaled, and merged using the HKL software package (Z. Otwinowski and W. Minor, personal communication) .
Phasing, Model Building, and Refinement
Heavy atom positions were located by inspection or with RSPS (Collaborative Computation Project, 1994) and confirmed with cliff?fence Fou-. tier syntheses. Heavy atom parameters were refined with HEAVY (Terwilliger and Eisenberg, 1983 ) and phases were computed using either HEAVY or MLPHARE (Otwinowski, 1991) . MIR phases were improved and extended by cycles of solvent flattening (Wang, 1985) , phase combination (Reed, 1986) , and, when appropriate, histogram matching combined with Sayre's equation (Zhang and Main, 1990) within the CCP4 crystallographic package. The molecular model was built into electron density maps using QUANTA 4.1 (Molecular Simulations, Burlington, MA) and the model refined with X-PLOR 3.1 (Br(Jnger, 1993) . Refinement of the PIP and Pb(NO3)2 derivatives, including the anomalous contribution from the lead, gave a figure of merit of 0.53 for data to 4.6 A. The resulting MIRAS map was subjected to cycles of solvent flattening, phase combination, and phase extension to produce an electron density map at 4.0 ~,. A partial model for CnA and CnB could readily be built into this map, and FKBP12 was positioned into the density as a rigid body. At this stage, the partial structure was refined against the first native data set collected (native 1) and then refined as a rigid body against a new native data set (native 2) collected from crystals stabilized in 0.1 M potassium phosphate (pH 7.5) and 12% PEG 8000 and cryoprotected with 0.1 M postassium phosphate (pH 7.5), 90/0 PEG 8000, and 23% ethylene glycol. These conditions yielded yet another cell, with dimensions a = 91.3 ~,, b = 94.4 h,, and c = 116.8, but resulted in much higher resolution diffraction data. Three new derivatives, soaked and cryoprotected under the same conditions as native 2, were obtained with HgCI2, Pb(NO3)2, and K2PtCI4. Heavy atom parameter refinement for these threederivatives against native 2 gave a final figure of merit of 0.58-3.3 A, including the lead anomalous data. This MIRAS map was again subjected to cycles of solvent flattening and phase extension, and multiple electron density maps were calculated, ranging from 3.6 to 2.6/~ resolution. The resulting maps showed clear density in which approximately 80% of the CnA and CnB chains could be built as polyalanine, beginning with the previous model. Strong density was also readily apparent for FK506 and a putative CnA active site at this stage, but these regions were intentionally left unbuilt until the latter stages of model building to leave them as unbiased as possible. Multiple rounds of model building, positional refinement, phase combination, and phase extension gave improved electron density maps into which a nearly complete model of the ternary complex was built. The positions of the lead, mercury, and platinum heavy atoms helped to confirm the assigned sequence register during building of loops and side chains in the final stages. A nearly complete ternary complex model was subjected to simulated annealing refinement from 3000 K to 200 K at 2.8 ,~ resolution followed by positional refinement. The remaining loops and side chains, along with FK506 and well-ordered water molecules, were built into 21Fo IJF~la~ and IFo) -IF~ja~ difference Fourier maps. The current model contains residues 24-370 of CnA (excluding residues 241-246, which are presumed disordered); residues 1-168 of CnB, including an N-terminal myristoyl group; FKBP12-FK506; four Ca 2+ ions in the CnB Ca ~*-binding sites; one phosphate, one Fe 3+ ion, and one Zn 2÷ ion in the CnA active site; and 87 water molecules. The current R factor for data between 6.0 and 2.5 ,~ (29657 reflections with IFI > 1.5 o(F)) is 22.0%, and the free R factor IBr(Jnger, 1992) is 32.80/0. The rms deviation from ideality is 0.020 A for bond lengths and 3.8 ° for bond angles, with good sterecchemistry for backbone torsion angles.
Superimposition of Rapamycin
The FKBP12-rapamycin structure (at 1.7 ,~,, R = 18.1% ; Wilson et al., 1995) was superimposed on the FKBP12 in the ternary structure using 428 backbone atoms within the rigid-body fit option QUANTA 4.1. The backbone atoms superimposed with 0.9 Arms deviations.
